Tokyo, March 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060792) titled 'A Study on Glucose Control and Quality of Life Improvement in Type 1 Diabetes Patients Following Switching from SAP770G to 780G A Prospective Observational Study' on March 2.
Study Type:
Observational
Primary Sponsor:
Institute - Kushiro Red Cross Hospital
Condition:
Condition - Type 1 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to evaluate changes in metabolic parameters, including blood glucose, and quality of life (QOL) indicators in type 1 diabetes patients currently undergoing insulin pump therapy with the 70G system, following their transition to the 780G system.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - The inclusion criteria were a diagnosis of type 1 diabetes and treatment with the MiniMed 770G system.
Key exclusion criteria - Patients for whom participation in this study is difficult due to concomitant severe liver disease.
Patients deemed inappropriate for participation by the principal investigator or subinvestigators for any other reason.
Target Size - 10
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2024 Year 04 Month 12 Day
Date of IRB - 2024 Year 05 Month 12 Day
Anticipated trial start date - 2024 Year 05 Month 12 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069554
Disclaimer: Curated by HT Syndication.
